Home › Sleep Disorders › Texas › Dallas
Sleep Disorders clinical trials in Dallas, TX
4 studies for Sleep Disorders are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
RecruitingPhase 3
- Velocity Clinical Research, Dallas, Dallas
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Dallas, Texas, Dallas
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Dallas
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
RecruitingPhase 3
- Alkermes Investigational Site, Dallas
About Sleep Disorders
Getting a good sleep is vital to your health, but many Americans don't get enough. Learn about sleep disorders, treatments, and good sleep habits.
More about Sleep Disorders on MedlinePlus
Sleep Disorders trials in other cities
- San Antonio, TX6 studies
- Lansing, MI5 studies
- Cincinnati, OH5 studies
- Sugar Land, TX5 studies
- Charlotte, NC5 studies
- Orlando, FL5 studies
- Brandon, FL5 studies
- Macon, GA4 studies
- Austin, TX4 studies
- Miami, FL4 studies
- Columbia, SC4 studies
- Atlanta, GA4 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.